Resource

 

 

 

 

 

 

 

 

 

 

 

M&A: Seller's Counsel

Dechert Advises Cerberus and PaxVax on Sale of PaxVax to Emergent BioSolutions

16 Aug 2018

Dechert LLP is advising Cerberus Capital Management, L.P. (“Cerberus”) and PaxVax Global, L.P., which is majority-owned by investment funds and accounts affiliated with Cerberus, in connection with the sale of PaxVax Holding Company Ltd. and its subsidiaries, a specialty vaccine company, to Emergent BioSolutions Inc. (NYSE: EBS). The all-cash purchase price for the cross-border transaction is US$270 million, subject to customary closing conditions (including U.S., Spanish and Portuguese antitrust regulatory approval).

Herbert Smith Freehills advises Capilano Honey on A$190 million takeover proposal from Roc Partners and Wattle Hill

16 Aug 2018

Herbert Smith Freehills is advising premium Australian honey company, Capilano Honey Limited on the A$190 million takeover proposal from a consortium which consists private equity funds Roc Partners and Wattle Hill. The Capilano Board considers the consortium’s $20.06 per share offer to provide an attractive premium to the recent trading price of Capilano shares, particularly given liquidity of the stock is low.

Electronic Data Processing Completes Multi-Million Pound Sale

16 Aug 2018

Irwin Mitchell Advises On £12m Deal

The Sheffield office of law firm Irwin Mitchell has advised Electronic Data Processing Plc on its £12m sale to Eagle Bidco 2018 Limited.

The boards of EDP and Eagle Bidco 2018 Ltd reached an agreement on the terms of a recommended cash offer in July. The acquisition was sanctioned by the High Court last week and has completed today.

Milbank Advises ProSieben Travel GmbH on the Sale of Tropo to dnata

14 Aug 2018

The international law firm Milbank, Tweed, Hadley & McCloy LLP has advised ProSieben Travel GmbH, a 100% subsidiary of ProSiebenSat.1 Media SE, on the sale of all shares of the tour operator Tropo to dnata, one of the world’s largest air services providers. The purchase agreement also includes TV media volume worth several million euros for 2018 and 2019.

Corrs advises Wesfarmers on A$350 million sale of its Kmart Tyre and Auto Service business

14 Aug 2018

Australia’s leading independent law firm, Corrs Chambers Westgarth, has advised Wesfarmers on the sale of its Kmart Tyre and Auto Service business to Continental AG for A$350 million.

The Kmart Tyre and Auto Service (KTAS) business is one of Australia’s largest tyre, automotive and repair retailers, with 258 stores across Australia and over 1,200 employees. Wesfarmers had acquired the KTAS business as part of its acquisition of the Coles Group in 2007.

Allen & Overy advises M&C on the sale of Treofan Holdings

14 Aug 2018

Allen & Overy has advised Italian holding company M&C S.p.A. ("M&C") with its registered office in Milan on the sale of its majority shareholding of 98.75 percent in Treofan Holdings GmbH ("Treofan Holdings") to a company of the Indian B.C. Jindal Group.

Following the sale of Treofan's North American business, Treofan Americas, to Canadian CCL Industries Inc. in the beginning of July 2018, which was also accompanied by Allen & Overy, the transaction is part of a share deal and includes all remaining group companies of Treofan Holdings.

Baker McKenzie advises Westinghouse Electric Company on $4.6 billion sale to Brookfield Business Partners

13 Aug 2018

Leading global law firm Baker McKenzie has acted as co-counsel to Westinghouse, the global leader in nuclear technology, fuel and services in relation to their sale to Brookfield Business Partners and their emergence from Chapter 11 as a reorganised company. The deal closed on 1 August 2018 having received regulatory approval and following approval by the bankruptcy court.

Milbank Advises gruppeH GmbH on the Sale of All Shares in humediQ Global GmbH to Varian Medical Systems, Inc.

11 Aug 2018

The international law firm Milbank, Tweed, Hadley & McCloy LLP advised gruppeH GmbH on the sale of all shares in humediQ global GmbH ("humediQ") to Varian Medical Systems, Inc. ("Varian"), a global leader in the radiotherapy of tumor diseases.

humediQ, headquartered in Munich, Germany, is focused on the development, production and sales of hardware and software solutions for quality assurance in radiotherapy. The key product of humediQ is IDENTIFY, an automated patient identification, positioning and motion manage-ment system for radiation therapy.